Krystal Biotech, Inc. Income Taxes Paid
Krystal Biotech, Inc. (KRYS) reported Income Taxes Paid of $13.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-03
- Krystal Biotech, Inc. income taxes paid for the quarter ending 2026-06-30 was $13.20M, a 1.95% decline year-over-year.
- Krystal Biotech, Inc. income taxes paid for the quarter ending 2026-03-31 was $627.00K, a 56.75% increase year-over-year.
- Krystal Biotech, Inc. income taxes paid for the quarter ending 2025-06-30 was $13.46M.
- Krystal Biotech, Inc. income taxes paid for the quarter ending 2025-03-31 was $400.00K.
- Krystal Biotech, Inc. income taxes paid for fiscal 2025 was $15.67M, a 176.66% increase from fiscal 2024.
- Krystal Biotech, Inc. income taxes paid for fiscal 2024 was $5.67M.
- Krystal Biotech, Inc. income taxes paid for fiscal 2023 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 12 month |
|---|---|---|---|
| 2026-06-30 | $13.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $13.82M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $627.00K 10-Q · filed 2026-05-04 | ||
| 2025-12-31 | $15.67M 10-K · filed 2026-02-17 | ||
| 2025-06-30 | $13.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $13.86M 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-04 | ||
| 2024-12-31 | $5.67M 10-K · filed 2026-02-17 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |